Q: I heard about a Million Pound Challenge that was launched at the What’s Next Longevity Innovation Summit last December.
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results